APA (7th ed.) Citation

JH, V., A, H., F, C., MC, P., EM, L., KA, J., & LT, F. (2023). Attention-deficit/hyperactivity disorder (ADHD) symptoms and their relation to diagnosed ADHD, sociodemographic characteristics, and substance use among patients receiving opioid agonist therapy: A Norwegian cohort study. BMC psychiatry, 23(1), 479. https://doi.org/10.1186/s12888-023-04980-w

Chicago Style (17th ed.) Citation

JH, Vold, Halmøy A, Chalabianloo F, Pierron MC, Løberg EM, Johansson KA, and Fadnes LT. "Attention-deficit/hyperactivity Disorder (ADHD) Symptoms and Their Relation to Diagnosed ADHD, Sociodemographic Characteristics, and Substance Use Among Patients Receiving Opioid Agonist Therapy: A Norwegian Cohort Study." BMC Psychiatry 23, no. 1 (2023): 479. https://doi.org/10.1186/s12888-023-04980-w.

MLA (9th ed.) Citation

JH, Vold, et al. "Attention-deficit/hyperactivity Disorder (ADHD) Symptoms and Their Relation to Diagnosed ADHD, Sociodemographic Characteristics, and Substance Use Among Patients Receiving Opioid Agonist Therapy: A Norwegian Cohort Study." BMC Psychiatry, vol. 23, no. 1, 2023, p. 479, https://doi.org/10.1186/s12888-023-04980-w.